SALT LAKE CITY — The Salt Lake City Department of Economic Development announced the corporate headquarters relocation for a medical device company to Utah’s capital city, bringing with it hundreds of expected jobs over the next eight years.
Biomerics, a medical device maker for the cardiovascular market, is moving its headquarters to the city’s northwest quadrant, just west of Salt Lake City International Airport.
The planned 230,000-square-foot facility will include corporate and engineering offices, and research and development labs, as well as cleanroom manufacturing, a news release stated.
“Biomerics has seen incredible growth over the last few years, which has encouraged us to look more strategically at how we do business in Salt Lake City,” company CEO Travis Sessions said. “This new facility will enable us to better serve our customers, expand our current resources and invest in new opportunities.”
Scheduled for completion next year, the headquarters will accommodate up to 600 employees. The project is estimated to be a $38.5 million investment over next eight years, with more than 380 new jobs expected to be added to the company’s payroll, according to the statement.
The Governor’s Office of Economic Development is supporting the project with up to $3 million in tax incentives for the investment over the eight-year agreement period.
“Biomerics is an excellent addition to Salt Lake City and our growing life sciences sector,” Mayor Jackie Biskupski said. “Biomerics is at the cutting edge of technology in their field of work. They have pride in the footprint they leave in their community and with their employees. It is those values that make this company a perfect fit for the city.”
Craig McCaffrey, Biomerics’ Salt Lake division president, said Salt Lake City is an excellent business corridor to cities on the West Coast and internationally.
“It is a business-friendly climate that offers a quality of life that benefits the company and its employees,” McCaffrey said. “This new facility will enhance our capabilities as a medical device manufacturer.”
Established in 2009, Biomerics specializes in the design, development and production of medical devices for diagnostic and interventional procedures for the cardiovascular, structural heart, cardiac rhythm management and vascular access markets, the news release stated.
The company has five locations, including facilities in Ireland, Minnesota and Utah.